| Home | E-Submission | Sitemap | Editorial Office |  
Journal of Korean Neurosurgical Society 1990;19(10-12): 1422-1425.
Albendazole Therapy for Multiple Neurocysticercosis.
Gee Han Kwon, Jowa Hyuk Ihm
1Department of Neurology, Nonsan Baekjae Hospital, Nonsan, Korea.
2Department of Neurosurgery, Nonsan Baekjae Hospital, Nonsan, Korea.
Albendazole is a new drug for the treatment of cerebral cysticercosis. We have recently experience a case that had shown poor therapeutic response to praziquantel. The patient have multiple parenchymal cysts. She was treated with 15mg/kg/day of albendazole for 1 month to confirm healing of the intracranial lesion by the follow up brain CT scan and CSF-ELISA associated with marked clinical improvement.
Key Words: Albendazole; Neurocysticercosis; Chemotherapy
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Related articles
A Case of Cerebral Multiple Cysticercosis: Case Report.  1976 October;5(2)
A Case of Third Ventricular Cysticercosis.  1990 March;19(3)
Stereotactic Surgery of Neurocysticercosis.  1996 April;25(4)
Editorial Office
1F, 18, Heolleung-ro 569-gil, Gangnam-gu, Seoul, Republic of Korea
TEL: +82-2-525-7552   FAX: +82-2-525-7554   E-mail: office@jkns.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Neurosurgical Society.                 Developed in M2PI
Close layer